3,4-dihydroxyphenylacetic acid has been researched along with Amentia in 6 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily for a week, followed by 100 mg four times daily for 12 weeks." | 7.66 | Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. ( Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA, 1982) |
| "Mean levels of the two hydrolases angiotensin-converting enzyme (ACE) and acetylcholinesterase (AChE), the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and total protein concentration were examined in cerebrospinal fluid (CSF) samples from a group of patients with dementia of the Alzheimer's type, a group of comparably demented patients with Parkinson's disease, and a neurologically healthy elderly control group." | 3.67 | Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. ( Direnfeld, LK; Langlais, PJ; Marquis, JK; Nixon, RA; Volicer, L; Zubenko, GS, 1986) |
| "In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily for a week, followed by 100 mg four times daily for 12 weeks." | 3.66 | Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. ( Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, P | 1 |
| Ayton, S | 1 |
| Appukuttan, AT | 1 |
| Volitakis, I | 1 |
| Adlard, PA | 1 |
| Finkelstein, DI | 1 |
| Bush, AI | 1 |
| Yesavage, JA | 1 |
| Tinklenberg, JR | 1 |
| Hollister, LE | 1 |
| Berger, PA | 1 |
| Lindner, MD | 1 |
| Cain, CK | 1 |
| Plone, MA | 1 |
| Frydel, BR | 1 |
| Blaney, TJ | 1 |
| Emerich, DF | 1 |
| Hoane, MR | 1 |
| Zubenko, GS | 1 |
| Marquis, JK | 1 |
| Volicer, L | 1 |
| Direnfeld, LK | 1 |
| Langlais, PJ | 1 |
| Nixon, RA | 1 |
| Nakamura, S | 1 |
| Fukuda, H | 1 |
| Hara, K | 1 |
| Fukuyama, H | 1 |
| Kameyama, M | 1 |
| Bridge, TP | 1 |
| Kleinman, JE | 1 |
| Karoum, F | 1 |
| Wyatt, RJ | 1 |
6 other studies available for 3,4-dihydroxyphenylacetic acid and Amentia
| Article | Year |
|---|---|
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Clioquinol; Dementia; Disease Models, Animal; Dopami | 2015 |
Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Dementia; Furans; Glucose; Homovanillic Acid; Humans; Hydroxyi | 1982 |
Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Brain Mapping; Corpus Striatum; Dementia; Dopa | 1999 |
Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Aged; Alzheimer Disease; Cerebrospinal Fluid P | 1986 |
Biochemical aspects of Parkinson-dementia complex.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dement | 1988 |
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Brain Chemistry; Catecholamines; Cognition; Dementia; Dopamine | 1985 |